Low Expression of PAI-2 as a Novel Marker of Portal Vein Tumor Thrombosis and Poor Prognosis in Hepatocellular Carcinoma

Characterisation of a novel cell line (CSQT-2) with high metastatic activity derived from portal vein tumour thrombus of hepatocellular carcinoma

(2010) T Wang et al.   BRITISH JOURNAL OF CANCER

Predictors of microvascular invasion before hepatectomy for hepatocellular carcinoma

(2010) Masaki Kaibori et al.   JOURNAL OF SURGICAL ONCOLOGY

Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies

(2009) Puneeta Tandon et al.   LIVER INTERNATIONAL

Survival after liver transplantation for hepatocellular carcinoma in the model for end-stage liver disease and pre-model for end-stage liver disease eras and the independent impact of hepatitis C virus

(2009) Paul J. Thuluvath et al.   LIVER TRANSPLANTATION

Rb Depletion Results in Deregulation of E-Cadherin and Induction of Cellular Phenotypic Changes that Are Characteristic of the Epithelial-to-Mesenchymal Transition

(2008) Y. Arima et al.   CANCER RESEARCH

Evolving role of uPA/uPAR system in human cancers

(2008) Kathleen Dass et al.   CANCER TREATMENT REVIEWS

Prognostic factors after liver resection for hepatocellular carcinoma with hepatitis B virus-related cirrhosis: The surgeon's role in survival

(2008) X.-F. Zhang et al.   EJSO

Role of overexpression of CD151 and/or c-Met in predicting prognosis of hepatocellular carcinoma

(2008) Ai-Wu Ke et al.   HEPATOLOGY

TOP2A overexpression in hepatocellular carcinoma correlates with early age onset, shorter patients survival and chemoresistance

(2008) Nathalie Wong et al.   INTERNATIONAL JOURNAL OF CANCER

Risk Factors and Prognostic Factors of Local Recurrence after Radiofrequency Ablation of Hepatocellular Carcinoma

(2008) Vincent Wai-To Lam et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS